These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Lipofection of a cDNA plasmid containing the dystrophin gene lowers intracellular free calcium and calcium leak channel activity in mdx myotubes. McCarter GC; Denetclaw WF; Reddy P; Steinhardt RA Gene Ther; 1997 May; 4(5):483-7. PubMed ID: 9274726 [TBL] [Abstract][Full Text] [Related]
34. Full-length dystrophin gene transfer to the mdx mouse in utero. Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052 [TBL] [Abstract][Full Text] [Related]
35. Molecular targets to treat muscular dystrophies. Kinter J; Sinnreich M Swiss Med Wkly; 2014 Feb; 144():w13916. PubMed ID: 24554202 [TBL] [Abstract][Full Text] [Related]
36. More deletions in the 5' region than in the central region of the dystrophin gene were identified among Filipino Duchenne and Becker muscular dystrophy patients. Cutiongco EM; Padilla CD; Takenaka K; Yamasaki Y; Matsuo M; Nishio H Am J Med Genet; 1995 Nov; 59(2):266-7. PubMed ID: 8588598 [No Abstract] [Full Text] [Related]
38. Human dystrophin gene transfer: genetic correction of dystrophin deficiency. Dickson G; Dunckley M Mol Cell Biol Hum Dis Ser; 1993; 3():283-302. PubMed ID: 8111543 [No Abstract] [Full Text] [Related]
39. [Deletion analysis of the dystrophin gene in patients with Duchenne's muscular dystrophy in Tajikistan]. Odinokova ON; Puzyrev VP; Radzhabaliev ShF; Rakhmonov RA Genetika; 1996 Oct; 32(10):1392-5. PubMed ID: 9091412 [TBL] [Abstract][Full Text] [Related]
40. [Current state and prospects for gene therapy of Duchenne muscular dystrophy in the world and in Russia]. Baranov VS; Baranov AN; Zelenin AV Genetika; 2001 Aug; 37(8):1046-54. PubMed ID: 11642103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]